References
- Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 2001; 24(8): 1460–7
- Balme M, McAllister I, Davis WA, et al. Retinopathy in latent autoimmune diabetes of adults: the Fremantle Diabetes Study. Diabet Med 2002; 19(7): 602–5
- Falorni A, Calcinare F. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Ann N Y Acad Sci 2002; 958: 99–106
- Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350(9087): 1288–93 [Erratum, Lancet 1998; 351(9099): 376]
- Torn C, Landin-Olsson M, Ostman J, et al. Glutamic acid decarboxylase autoantibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 2000; 16(6): 442–7
- Palmer JP, Hirsch IB. What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes. Diabetes Care 2003; 26(2): 536–8
- Isomaa B, Almgren P, Henricsson M, et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 1999; 22(8): 1347–53
- Nakanishi K, Kobayashi T, Inoko H, et al. Residual beta-cell function and HLA-A24 in IDDM: markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes 1995; 44(11): 1334–9
- Maruyama T, Shimada A, Kanatsuka A, et al. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci 2003; 1005: 362–9
- Beales PE, Giorgini A, Annovazzi A, et al. Metformin does not alter diabetes incidence in the NOD mouse. Horm Metab Res 1997; 29(6): 261–3
- Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev 2002; 18(2): 114–7
- Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346(22): 1685–91